Literature DB >> 24513404

Short-term effects of an endotoxin on substantia nigra dopamine neurons.

Kaela R S Reinert1, Claudia D Umphlet1, Ariana Quattlebaum1, Heather A Boger2.   

Abstract

Inflammation has been implicated in the pathology of several neurodegenerative diseases, including Parkinson׳s disease (PD). Studies using the endotoxin lipopolysaccharide (LPS), a potent inflammogen, show that systemic insults can trigger prolonged microglial activation and pro-inflammatory cytokine production leading to degeneration of substantia nigra (SN) dopamine (DA) neurons, mimicking idiopathic PD. Because rapid effects of LPS on SN neurons had not been investigated previously, the focus of this study is to assess time-dependent alterations in SN neuroinflammation, DAergic neurons, and neuronal signaling cascades following LPS administration. LPS (5mg/kg, i.p.) or saline (0.9% NaCl) was administered to 8-month-old male mice. At 3h, 5h, and 12h post-injection, the morphology of the SN was assessed using antibodies directed against tyrosine hydroxylase (TH, DAergic marker), Iba-1 (pan-microglial marker), phospho-ERK, and phospho-CREB (signaling). LPS administration significantly reduced TH-immunoreactivity (ir) at all time-points with the greatest reduction observed at 12h post-injection. Reduced TH-ir was accompanied by a significant increase in activated microglia at all time-points following LPS. By 12h post-injection, LPS-treated mice exhibited activated as well as reactive microglia, which can result in neuronal damage. These data demonstrate that the initial reduction in TH-ir observed after an LPS injection was not concomitant with morphological alterations in microglial cells, even though a significant increase in phospho-ERK was observed in glial cells as soon as 3h post-injection. It is possible that the initial alteration in DA phenotype (TH reduction) may perpetuate an inflammatory response that persists and leads to further DAergic damage. Published by Elsevier B.V.

Entities:  

Keywords:  Dopamine; Inflammation; Lipopolysaccharide; Substantia nigra

Mesh:

Substances:

Year:  2014        PMID: 24513404      PMCID: PMC3970422          DOI: 10.1016/j.brainres.2014.02.005

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration.

Authors:  Liya Qin; Xuefei Wu; Michelle L Block; Yuxin Liu; George R Breese; Jau-Shyong Hong; Darin J Knapp; Fulton T Crews
Journal:  Glia       Date:  2007-04-01       Impact factor: 7.452

Review 2.  Microglia: biology and pathology.

Authors:  Manuel B Graeber; Wolfgang J Streit
Journal:  Acta Neuropathol       Date:  2009-12-13       Impact factor: 17.088

3.  Age-dependent neurovascular abnormalities and altered microglial morphology in the YAC128 mouse model of Huntington disease.

Authors:  Sonia Franciosi; Jae K Ryu; Yaein Shim; Austin Hill; Colum Connolly; Michael R Hayden; James G McLarnon; Blair R Leavitt
Journal:  Neurobiol Dis       Date:  2011-09-13       Impact factor: 5.996

4.  A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra.

Authors:  H A Boger; L D Middaugh; P Huang; V Zaman; A C Smith; B J Hoffer; A C Tomac; A-Ch Granholm
Journal:  Exp Neurol       Date:  2006-08-02       Impact factor: 5.330

Review 5.  The initiation of the microglial response.

Authors:  H Kato; W Walz
Journal:  Brain Pathol       Date:  2000-01       Impact factor: 6.508

6.  Dentate granule neuron apoptosis and glia activation in murine hippocampus induced by trimethyltin exposure.

Authors:  A Fiedorowicz; I Figiel; B Kamińska; M Zaremba; S Wilk; B Oderfeld-Nowak
Journal:  Brain Res       Date:  2001-09-07       Impact factor: 3.252

7.  Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice.

Authors:  Randy L Hunter; Baohua Cheng; Dong-Young Choi; Mei Liu; Shuwei Liu; Wayne A Cass; Guoying Bing
Journal:  J Neurosci Res       Date:  2009-06       Impact factor: 4.164

Review 8.  Microglia: neuroprotective and neurotrophic cells in the central nervous system.

Authors:  Kazuyuki Nakajima; Shinichi Kohsaka
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2004-03

9.  Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway.

Authors:  Maria Grazia Giovannini; Carla Scali; Costanza Prosperi; Arianna Bellucci; Maria Giuliana Vannucchi; Susanna Rosi; Giancarlo Pepeu; Fiorella Casamenti
Journal:  Neurobiol Dis       Date:  2002-11       Impact factor: 5.996

10.  Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation.

Authors:  Edgar Alfonso Romero-Sandoval; Ryan Horvath; Russell P Landry; Joyce A DeLeo
Journal:  Mol Pain       Date:  2009-05-28       Impact factor: 3.395

View more
  12 in total

Review 1.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

2.  Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.

Authors:  Ariana Q Farrand; Kristi L Helke; Rebecca A Gregory; Monika Gooz; Vanessa K Hinson; Heather A Boger
Journal:  Brain Stimul       Date:  2017-08-24       Impact factor: 8.955

Review 3.  Inflammatory Animal Models of Parkinson's Disease.

Authors:  Juan García-Revilla; Antonio J Herrera; Rocío M de Pablos; José Luis Venero
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

4.  Effects of a Short-Term Lipopolysaccharides Challenge on Mouse Brain and Liver Peroxisomal Antioxidant and β-oxidative Functions: Protective Action of Argan Oil.

Authors:  Soukaina Essadek; Habiba Bouchab; Riad El Kebbaj; Catherine Gondcaille; Soufiane El Kamouni; Stéphane Savary; Joseph Vamecq; Abdelkhalid Essamadi; Mustapha Cherkaoui-Malki; Boubker Nasser; Pierre Andreoletti
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-12

5.  Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation.

Authors:  Serena Becchi; Alberto Buson; Jonathan Foot; Wolfgang Jarolimek; Bernard W Balleine
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

6.  Pioglitazone Attenuates Lipopolysaccharide-Induced Oxidative Stress, Dopaminergic Neuronal Loss and Neurobehavioral Impairment by Activating Nrf2/ARE/HO-1.

Authors:  Aya Zakaria; Mona Rady; Laila Mahran; Khaled Abou-Aisha
Journal:  Neurochem Res       Date:  2019-11-12       Impact factor: 3.996

Review 7.  The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation.

Authors:  Larissa N Dooley; Kate R Kuhlman; Theodore F Robles; Naomi I Eisenberger; Michelle G Craske; Julienne E Bower
Journal:  Neurosci Biobehav Rev       Date:  2018-09-07       Impact factor: 8.989

Review 8.  Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration.

Authors:  Roman Sankowski; Simone Mader; Sergio Iván Valdés-Ferrer
Journal:  Front Cell Neurosci       Date:  2015-02-02       Impact factor: 5.505

9.  Chronic social stress induces peripheral and central immune activation, blunted mesolimbic dopamine function, and reduced reward-directed behaviour in mice.

Authors:  Giorgio Bergamini; Jonas Mechtersheimer; Damiano Azzinnari; Hannes Sigrist; Michaela Buerge; Robert Dallmann; Robert Freije; Afroditi Kouraki; Jolanta Opacka-Juffry; Erich Seifritz; Boris Ferger; Tobias Suter; Christopher R Pryce
Journal:  Neurobiol Stress       Date:  2018-02-02

10.  Are Temporal Differences in GDNF and NOS Isoform Induction Contributors to Neurodegeneration? A Fluorescence Microscopy-Based Study.

Authors:  Marie-Francoise Doursout; Yangyan Liang; Mya C Schiess; Angelica Padilla; Brian J Poindexter; Diane L M Hickson-Bick; Roger J Bick
Journal:  Open Neurol J       Date:  2016-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.